DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$4.16 USD
+0.03 (0.73%)
Updated Sep 19, 2024 09:30 AM ET
2-Buy of 5 2
D Value F Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for DiaMedica Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -19.38 | -13.68 | -13.59 | -12.29 | -10.65 |
Depreciation/Amortization & Depletion | -1.19 | 0.01 | 0.19 | 0.02 | -0.05 |
Net Change from Assets/Liabilities | 0.09 | 0.59 | -0.46 | 1.20 | 0.39 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.75 | 1.57 | 1.62 | 1.90 | 1.21 |
Net Cash From Operating Activities | -18.73 | -11.51 | -12.25 | -9.19 | -9.10 |
Property & Equipment | -0.02 | -0.08 | -0.02 | -0.03 | 0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -18.28 | 11.62 | -20.52 | -16.10 | -3.92 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -18.30 | 11.54 | -20.54 | -16.13 | -3.91 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 36.85 | 0.00 | 30.09 | 28.85 | 0.08 |
Issuance (Repayment) of Debt | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 36.84 | -0.01 | 30.09 | 28.85 | 0.07 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -0.19 | 0.02 | -2.70 | 3.53 | -12.94 |
Cash at Beginning of Period | 4.73 | 4.71 | 7.41 | 3.88 | 16.82 |
Cash at End of Period | 4.54 | 4.73 | 4.71 | 7.41 | 3.88 |
Diluted Net EPS | -0.60 | -0.52 | -0.65 | -0.78 | -0.89 |
Fiscal Year End for DiaMedica Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.27 | -5.15 | -19.38 | -14.22 | -9.75 |
Depreciation/Amortization & Depletion | -0.63 | -0.32 | -1.19 | -0.83 | -0.42 |
Net Change from Assets/Liabilities | -1.24 | -1.69 | 0.09 | -1.14 | -0.79 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.97 | 0.51 | 1.75 | 1.28 | 0.84 |
Net Cash From Operating Activities | -11.17 | -6.65 | -18.73 | -14.92 | -10.12 |
Property & Equipment | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 8.95 | 4.22 | -18.28 | -24.40 | -25.61 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 8.94 | 4.21 | -18.30 | -24.42 | -25.62 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 11.75 | 0.00 | 36.85 | 36.85 | 36.85 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 11.75 | 0.00 | 36.84 | 36.84 | 36.85 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 9.52 | -2.45 | -0.19 | -2.50 | 1.11 |
Cash at Beginning of Period | 4.54 | 4.54 | 4.73 | 4.73 | 4.73 |
Cash at End of Period | 14.07 | 2.10 | 4.54 | 2.23 | 5.84 |
Diluted Net EPS | -0.13 | -0.14 | -0.12 | -0.12 | -0.16 |